Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data

被引:22
作者
Aalto, Sargo [1 ,2 ]
Scheinin, Noora M. [1 ]
Kemppainen, Nina M. [1 ,3 ]
Nagren, Kjell [1 ]
Kailajarvi, Marita [4 ,5 ,6 ]
Leinonen, Mika [7 ]
Scheinin, Mika [4 ,5 ]
Rinne, Juha O. [1 ]
机构
[1] Univ Turku, Turku PET Ctr, FI-20521 Turku, Finland
[2] Abo Akad Univ, Dept Psychol, Turku, Finland
[3] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland
[4] Univ Turku, Dept Pharmacol, FI-20521 Turku, Finland
[5] Univ Turku, Clin Res Serv Turku, FI-20521 Turku, Finland
[6] GE Healthcare, Turku Imanet, Turku, Finland
[7] 4 Pharma Ltd, Turku, Finland
基金
芬兰科学院;
关键词
Alzheimer's disease; PET; PIB; Reproducibility; Test-retest; Voxel-based; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; BINDING; HUMANS;
D O I
10.1007/s00259-009-1174-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Positron emission tomography (PET) with (11)C-labelled Pittsburgh compound B ([(11)C]PIB) enables the quantitation of beta-amyloid accumulation in the brain of patients with Alzheimer's disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [(11)C]PIB PET data. The purpose of this study was to evaluate both region- and voxel- level reproducibility of automated and simplified [(11)C]PIB quantitation when using only 30 min of imaging data. Methods Six AD patients and four healthy controls were scanned twice with an average interval of 6 weeks. To evaluate the feasibility of short scanning (convenient for AD patients), [(11)C]PIB uptake was quantitated using 30 min of imaging data (60 to 90 min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intra-class correlation coefficients at both region-of-interest (ROI) and voxel level. Results The reproducibility both at the region level (VAR 0.9-5.5%) and at the voxel level (VAR 4.2-6.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [(11)C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group. Conclusion Our results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [(11)C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of AD patients for the evaluation of progression and treatment effects.
引用
收藏
页码:1651 / 1660
页数:10
相关论文
共 19 条
[1]  
Blomquist Gunnar, 2008, Open Neuroimag J, V2, P114, DOI 10.2174/1874440000802010114
[2]   Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease [J].
Brück, A ;
Aalto, S ;
Nurmi, E ;
Bergman, J ;
Rinne, JO .
NEUROBIOLOGY OF AGING, 2005, 26 (06) :891-898
[3]   Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study [J].
Edison, P. ;
Archer, H. A. ;
Hinz, R. ;
Hammers, A. ;
Pavese, N. ;
Tai, Y. F. ;
Hotton, G. ;
Cutler, D. ;
Fox, N. ;
Kennedy, A. ;
Rossor, M. ;
Brooks, D. J. .
NEUROLOGY, 2007, 68 (07) :501-508
[4]   Two-year follow-up of amyloid deposition in patients with Alzheimer's disease [J].
Engler, Henry ;
Forsberg, Anton ;
Almkvist, Ove ;
Blomquist, Gunnar ;
Larsson, Emma ;
Savitcheva, Irina ;
Wall, Anders ;
Ringheim, Anna ;
Langstrom, Bengt ;
Nordberg, Agneta .
BRAIN, 2006, 129 :2856-2866
[5]  
Friston K., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402
[6]  
Hooper PK, 1996, J NUCL MED, V37, P128
[7]   High intensity exercise decreases global brain glucose uptake in humans [J].
Kemppainen, J ;
Aalto, S ;
Fujimoto, T ;
Kalliokoski, KK ;
Långsjö, J ;
Oikonen, V ;
Rinne, J ;
Nuutila, P ;
Knuuti, J .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 568 (01) :323-332
[8]   PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment [J].
Kemppainen, N. M. ;
Aalto, S. ;
Wilson, I. A. ;
Nagren, K. ;
Helin, S. ;
Bruck, A. ;
Oikonen, V. ;
Kailajarvi, M. ;
Scheinin, M. ;
Viitanen, M. ;
Parkkola, R. ;
Rinne, J. O. .
NEUROLOGY, 2007, 68 (19) :1603-1606
[9]   Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease [J].
Kemppainen, N. M. ;
Aalto, S. ;
Wilson, I. A. ;
Nagren, K. ;
Helin, S. ;
Bruck, A. ;
Oikonen, V. ;
Kailajarvi, M. ;
Scheinin, M. ;
Viitanen, M. ;
Parkkola, R. ;
Rinne, J. O. .
NEUROLOGY, 2006, 67 (09) :1575-1580
[10]   Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B [J].
Klunk, WE ;
Engler, H ;
Nordberg, A ;
Wang, YM ;
Blomqvist, G ;
Holt, DP ;
Bergström, M ;
Savitcheva, I ;
Huang, GF ;
Estrada, S ;
Ausén, B ;
Debnath, ML ;
Barletta, J ;
Price, JC ;
Sandell, J ;
Lopresti, BJ ;
Wall, A ;
Koivisto, P ;
Antoni, G ;
Mathis, CA ;
Långström, B .
ANNALS OF NEUROLOGY, 2004, 55 (03) :306-319